David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DO
3026
PUT
DELISTED
Diamond Offshore Drilling
DO
| $421K | ﹤0.01% |
+40,100
| New | +$424K |
|
3027
PUT
Fortinet
FTNT
$113B
| $420K | ﹤0.01% |
25,000
| – | – |
|
3028
PUT
LiveRamp
RAMP
$2.29B
| $420K | ﹤0.01% |
+7,700
| New | +$382K |
|
3029
BRC Group Holdings
RILY
$290M
| $419K | ﹤0.01% |
25,102
+11,010
| +78% | +$175K |
|
3030
Hewlett Packard
HPE
$70.8B
| $418K | ﹤0.01% |
27,082
-4,650
| -15% | -$71.7K |
|
3031
Clearwater Paper
CLW
$351M
| $417K | ﹤0.01% |
21,400
+8,508
| +66% | +$245K |
|
3032
Costamare
CMRE
$1.91B
| $417K | ﹤0.01% |
80,307
-9,377
| -10% | -$47.2K |
|
|
CADE
3033
DELISTED
Cadence Bancorporation
CADE
| $417K | ﹤0.01% |
+22,504
| New | +$427K |
|
3034
Gladstone Investment Corp
GAIN
$657M
| $415K | ﹤0.01% |
+35,803
| New | +$402K |
|
3035
City Holding Co
CHCO
$2.03B
| $414K | ﹤0.01% |
5,440
-8,910
| -62% | -$662K |
|
3036
CALL
Yelp
YELP
$1.29B
| $414K | ﹤0.01% |
+12,000
| New | +$434K |
|
3037
Kelly Services Class A
KELYA
$591M
| $412K | ﹤0.01% |
18,697
-3,135
| -14% | -$71.8K |
|
3038
Peoples Bancorp
PEBO
$1.42B
| $412K | ﹤0.01% |
13,292
+3,641
| +38% | +$117K |
|
3039
PUT
Reinsurance Group of America
RGA
$16B
| $412K | ﹤0.01% |
2,900
| – | – |
|
3040
CALL
National Beverage
FIZZ
$3.12B
| $410K | ﹤0.01% |
14,200
+4,200
| +42% | +$149K |
|
3041
AXIS Capital
AXS
$7.25B
| $407K | ﹤0.01% |
7,425
-209,023
| -97% | -$11.6M |
|
3042
EverQuote
EVER
$946M
| $406K | ﹤0.01% |
+54,633
| New | +$346K |
|
3043
Xencor
XNCR
$2.18B
| $406K | ﹤0.01% |
13,056
-64,229
| -83% | -$2.14M |
|
|
QHC
3044
DELISTED
Quorum Health Corporation
QHC
| $406K | ﹤0.01% |
289,839
+275,672
| +1,946% | +$742K |
|
3045
PUT
Shenandoah Telecom
SHEN
$680M
| $404K | ﹤0.01% |
9,100
+1,800
| +25% | +$84.5K |
|
3046
United Natural Foods
UNFI
$2.88B
| $404K | ﹤0.01% |
30,555
-3,949
| -11% | -$53.3K |
|
3047
CALL
Alarm.com
ALRM
$2.79B
| $402K | ﹤0.01% |
+6,200
| New | +$376K |
|
3048
CALL
Hershey
HSY
$37.6B
| $402K | ﹤0.01% |
+3,500
| New | +$381K |
|
3049
BlueLinx
BXC
$656M
| $401K | ﹤0.01% |
+15,046
| New | +$428K |
|
3050
PUT
Kinder Morgan
KMI
$68.9B
| $400K | ﹤0.01% |
20,000
-90,000
| -82% | -$1.68M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.